[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[@SonnetBio](/creator/twitter/SonnetBio)
"Our CEO Raghu Rao provides an update on SON-1010 highlighting progress in finding the optimal dose with atezolizumab monitoring patient safety and responses and preparing to test a higher dose as the study advances toward Part X. $SONN #Oncology #SolidTumors"  
[X Link](https://x.com/SonnetBio/status/1970109705369370638) [@SonnetBio](/creator/x/SonnetBio) 2025-09-22T12:55Z XXX followers, XXX engagements


"Our Fully Human Albumin-Binding (FHAB) construct is the foundation of a fully modular technology that enables the design of single or bifunctional biologic compounds that target solid tumors by binding albumin which in turn binds to FcRn GP60 and SPARC. $SONN"  
[X Link](https://x.com/SonnetBio/status/1971211303130690043) [@SonnetBio](/creator/x/SonnetBio) 2025-09-25T13:52Z XXX followers, XXX engagements


"#DidYouSee: We entered into a collaboration with Spanios to evaluate SON-1010 (IL-12-FHAB) using a patient-derived tumoroid platform to support an ongoing Phase X study in patients with sarcoma. Learn more: $SONN #Oncology #Sarcoma #SolidTumors"  
[X Link](https://x.com/SonnetBio/status/1979228418588758323) [@SonnetBio](/creator/x/SonnetBio) 2025-10-17T16:50Z XXX followers, XXX engagements